Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudil
- PMID: 16508135
- DOI: 10.1248/bpb.29.397
Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudil
Abstract
Pharmacological treatment for cerebral ischemia and cerebral vasospasm following subarachnoid hemorrhage (SAH) cannot attain sufficiently high concentrations of the drugs in the cerebrospinal fluid (CSF) without precipitating systemic side effects. We recently developed a liposomal drug delivery system for intrathecal application that can maintain effective concentrations of cerebral vasodilator, fasudil, in the CSF. A single intrathecal injection of liposomal fasudil could maintain a therapeutic drug concentration in the CSF over a period time due to their sustained-release property, significantly decreasing infarct size in a rat model of acute ischemia and reducing vasoconstriction of the rat and dog basilar artery in a model of SAH. In this review, we are introducing our new less-invasive intrathecal drug delivery system that provides an alternative and safe method to deliver therapeutic agents.
Similar articles
-
Neuroprotection by intrathecal application of liposome-entrapped fasudil in a rat model of ischemia.Neurol Med Chir (Tokyo). 2001 Mar;41(3):107-13; discussion 113-4. doi: 10.2176/nmc.41.107. Neurol Med Chir (Tokyo). 2001. PMID: 11372552
-
[Development of drug delivery system for intrathecal administration and its therapeutic effect on cerebral vasospasm and ischemia].Yakugaku Zasshi. 2004 Aug;124(8):541-7. doi: 10.1248/yakushi.124.541. Yakugaku Zasshi. 2004. PMID: 15297723 Review. Japanese.
-
Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats.J Clin Neurosci. 2001 Nov;8(6):557-61. doi: 10.1054/jocn.2001.0998. J Clin Neurosci. 2001. PMID: 11683605
-
Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after subarachnoid hemorrhage.Neurosurgery. 2001 Apr;48(4):894-900; discussion 900-1. doi: 10.1097/00006123-200104000-00041. Neurosurgery. 2001. PMID: 11322450
-
Intrathecal treatment of cerebral vasospasm.J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1201-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.005. Epub 2012 May 30. J Stroke Cerebrovasc Dis. 2013. PMID: 22651990 Review.
Cited by
-
Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.Am J Physiol Renal Physiol. 2007 Jul;293(1):F100-9. doi: 10.1152/ajprenal.00520.2006. Epub 2007 Apr 4. Am J Physiol Renal Physiol. 2007. PMID: 17409276 Free PMC article.
-
Drug delivery in leptomeningeal disease: Navigating barriers and beyond.Drug Deliv. 2024 Dec;31(1):2375521. doi: 10.1080/10717544.2024.2375521. Epub 2024 Jul 12. Drug Deliv. 2024. PMID: 38995190 Free PMC article. Review.
-
Fasudil improves short-term echocardiographic parameters of diastolic function in patients with type 2 diabetes with preserved left ventricular ejection fraction: a pilot study.Heart Vessels. 2015 Jan;30(1):89-97. doi: 10.1007/s00380-013-0458-3. Epub 2014 Jan 5. Heart Vessels. 2015. PMID: 24390764 Clinical Trial.
-
Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.J Control Release. 2020 Oct 10;326:222-244. doi: 10.1016/j.jconrel.2020.07.011. Epub 2020 Jul 16. J Control Release. 2020. PMID: 32681948 Free PMC article. Review.
-
The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress.Biomed Res Int. 2013;2013:430791. doi: 10.1155/2013/430791. Epub 2013 May 22. Biomed Res Int. 2013. PMID: 23762845 Free PMC article.
